Fortis Group Advisors LLC Acquires Shares of 3,693 Cardinal Health, Inc. $CAH

Posted by Brenda Bartman on May 22nd, 2026

Fortis Group Advisors LLC acquired a new stake in Cardinal Health, Inc. (NYSE:CAH – Free Report) during the 4th quarter, HoldingsChannel.com reports. The institutional investor acquired 3,693 shares of the company’s stock, valued at approximately $794,000.

Several other institutional investors and hedge funds have also recently modified their holdings of CAH. Integrated Wealth Concepts LLC increased its holdings in shares of Cardinal Health by 6.9% in the first quarter. Integrated Wealth Concepts LLC now owns 4,363 shares of the company’s stock valued at $601,000 after purchasing an additional 280 shares during the last quarter. Jones Financial Companies Lllp grew its stake in shares of Cardinal Health by 198.3% in the first quarter. Jones Financial Companies Lllp now owns 21,112 shares of the company’s stock valued at $27,000 after acquiring an additional 14,034 shares in the last quarter. Arrowstreet Capital Limited Partnership acquired a new position in shares of Cardinal Health in the second quarter valued at about $1,935,000. Cerity Partners LLC grew its stake in shares of Cardinal Health by 17.0% in the second quarter. Cerity Partners LLC now owns 40,426 shares of the company’s stock valued at $6,792,000 after acquiring an additional 5,880 shares in the last quarter. Finally, Nebula Research & Development LLC grew its stake in shares of Cardinal Health by 34.4% in the second quarter. Nebula Research & Development LLC now owns 10,334 shares of the company’s stock valued at $1,736,000 after acquiring an additional 2,646 shares in the last quarter. 87.17% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

Several equities analysts recently commented on CAH shares. Mizuho upped their price target on shares of Cardinal Health from $222.00 to $235.00 and gave the company an “outperform” rating in a research note on Friday, February 6th. Barclays upped their price target on shares of Cardinal Health from $243.00 to $258.00 and gave the company an “overweight” rating in a research note on Tuesday, February 24th. TD Cowen upped their price target on shares of Cardinal Health from $251.00 to $255.00 and gave the company a “buy” rating in a research note on Friday, May 1st. UBS Group set a $260.00 price target on shares of Cardinal Health and gave the company a “buy” rating in a research note on Friday, February 6th. Finally, Jefferies Financial Group upped their price target on shares of Cardinal Health from $220.00 to $270.00 and gave the company a “buy” rating in a research note on Thursday, January 22nd. One research analyst has rated the stock with a Strong Buy rating, fifteen have given a Buy rating and two have assigned a Hold rating to the company’s stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $241.80.

View Our Latest Analysis on Cardinal Health

Cardinal Health Stock Up 0.7%

Shares of Cardinal Health stock opened at $200.68 on Friday. The company has a market capitalization of $47.00 billion, a price-to-earnings ratio of 30.68, a PEG ratio of 1.18 and a beta of 0.53. Cardinal Health, Inc. has a 12-month low of $137.75 and a 12-month high of $233.60. The firm’s 50-day moving average price is $205.50 and its two-hundred day moving average price is $208.75.

Cardinal Health (NYSE:CAH – Get Free Report) last announced its quarterly earnings data on Thursday, April 30th. The company reported $3.17 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.79 by $0.38. The firm had revenue of $60.94 billion for the quarter, compared to the consensus estimate of $62.10 billion. Cardinal Health had a net margin of 0.62% and a negative return on equity of 92.61%. The business’s revenue for the quarter was up 11.0% on a year-over-year basis. During the same period in the prior year, the company posted $2.35 earnings per share. Cardinal Health has set its FY 2026 guidance at 10.700-10.80 EPS. On average, sell-side analysts expect that Cardinal Health, Inc. will post 10.76 earnings per share for the current year.

Cardinal Health Increases Dividend

The business also recently announced a quarterly dividend, which will be paid on Wednesday, July 15th. Stockholders of record on Wednesday, July 1st will be issued a $0.5158 dividend. This represents a $2.06 dividend on an annualized basis and a dividend yield of 1.0%. This is an increase from Cardinal Health’s previous quarterly dividend of $0.51. The ex-dividend date of this dividend is Wednesday, July 1st. Cardinal Health’s dividend payout ratio (DPR) is currently 31.19%.

About Cardinal Health

(Free Report)

Cardinal Health is a multinational healthcare services and products company headquartered in Dublin, Ohio. Tracing its roots to the early 1970s, the company has grown into a major provider of supply chain and distribution services for the healthcare sector. Cardinal Health operates across a range of service lines that support hospitals, health systems, pharmacies, physician offices and clinical laboratories.

The company’s core activities include the wholesale distribution of branded and generic pharmaceuticals, the supply and distribution of medical-surgical products, and the provision of logistics and inventory management solutions.